Hyaluronan (HA) regulates crucial cancer cell functions through interactions with its RHAMM and CD44 receptors.
Low molecular weight HA (LMWHA) enhances RHAMM expression to increase (p ≤ 0.01) HT1080 cells' growth.
RHAMM/β-catenin complex formation increases β-catenin intracellular pool.
LMWHA/RHAMM actions regulate fibrosarcoma cell proliferation via a β-catenin/c-myc signaling pathway.